D. Azria

发表

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Petra Seibold, Hubert Thierens, Alison M Dunning, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiogenomics: radiobiology enters the era of big data and team science.

Andre Dekker, Michael Baumann, Karin Haustermans, 2014, International journal of radiation oncology, biology, physics.

T lymphocytes to predict radiation-induced late effects in normal tissues

C. Bourgier, M. Brengues, A. Pèlegrin, 2017, Expert review of molecular diagnostics.

Metabolic functional imaging for tumor radiosensitivity monitoring.

David Azria, N. Magné, Y. Belkacemi, 2007, Critical reviews in oncology/hematology.

Independent component analysis for rectal bleeding prediction following prostate cancer radiotherapy.

M. Hatt, A. Kachenoura, O. Acosta, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Letrozole sensitizes breast cancer cells to ionizing radiation

P. Martineau, G. Romieu, P. Pujol, 2004, Breast Cancer Research.

Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy.

J. Solassol, A. Mangé, M. Ozsahin, 2015, Critical reviews in oncology/hematology.

Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial☆

Sébastien Clippe, Christophe Hennequin, André Pèlegrin, 2015, EBioMedicine.

Improving Patients’ Life Quality after Radiotherapy Treatment by Predicting Late Toxicities

M. Ozsahin, C. Bourgier, M. Brengues, 2022, Cancers.

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

J. Solassol, A. Mangé, M. Ozsahin, 2019, Radiation Oncology.

Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity

J. Chang-Claude, F. Wenz, C. West, 2019, Clinical and translational radiation oncology.

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.

J. Chang-Claude, T. Vercauteren, A. Dunning, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of genomics to balance cure and complications

B. Rosenstein, D. Azria, 2019, Nature Reviews Clinical Oncology.

In Regard to Pereira et al.

M. Ozsahin, C. Bourgier, M. Brengues, 2018, International journal of radiation oncology, biology, physics.

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial

C. Bourgier, C. Hennequin, F. Mornex, 2018, Oncotarget.

One Size Fits All: Does the Dogma Stand in Radiation Oncology?

C. Bourgier, M. Brengues, D. Azria, 2016, EBioMedicine.

Concurrent or sequential letrozole with adjuvant breast radiotherapy: primetime for personalized radiation oncology

C. Bourgier, D. Azria, 2016 .

Single Nucleotide Polymorphisms, Apoptosis, and the Development of Severe Late Adverse Effects After Radiotherapy

R. Mirimanoff, M. Ozsahin, N. Crompton, 2008, Clinical Cancer Research.

Identifying patients at risk for late radiation-induced toxicity.

M. Ozsahin, C. Bourgier, D. Azria, 2012, Critical reviews in oncology/hematology.

Proteomic approaches to identify biomarkers predictive of radiotherapy outcomes

J. Solassol, A. Mangé, D. Azria, 2013, Expert review of proteomics.

An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer

P. Colombo, N. Radosevic-Robin, C. Theillet, 2019, International journal of cancer.

[Recommendations Onco-Urology 2010: Prostate cancer].

L. Salomon, A. Villers, M. Peyromaure, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.

L. Quéro, T. Conroy, C. Borg, 2019, Clinical colorectal cancer.

Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: tolerance and efficacy.

T. Conroy, S. Gourgou-Bourgade, M. Jarlier, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.

T. Conroy, Y. Bécouarn, O. Bouché, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays

K. Pantel, M. Nowicki, M. Zabel, 2019, Cancers.

[Stereotactic body radiotherapy for liver tumors: State of the art].

F. Mornex, O. Riou, D. Azria, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe study.

I. Ray-Coquard, S. de Botton, M. Spielmann, 2012, European journal of cancer.

[Factors of late radiosensitivity of normal tissues].

M. Ozsahin, D. Azria, Y. Pointreau, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

["Dose-painting": myth or reality?].

F. Paris, P. Fenoglietto, S. Supiot, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Adjuvant early breast cancer systemic therapies according to daily used technologies.

G. Romieu, W. Jacot, D. Azria, 2012, Critical reviews in oncology/hematology.

[Value of positron emission tomography and computer tomography (PET/CT) for urologic malignancies].

John O. Prior, R. Mirimanoff, M. Ozsahin, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Comparison of volumetric-modulated arc therapy and dynamic conformal arc treatment planning for cranial stereotactic radiosurgery.

P. Fenoglietto, C. Kerr, D. Azria, 2016, Journal of applied clinical medical physics.

Surgery for Esophageal Cancer after Concomitant Radiochemotherapy: Oncologic and Functional Results

M. Ychou, P. Rouanet, C. Lemanski, 2004, World Journal of Surgery.

[Global brain metastases management strategy: a multidisciplinary-based approach].

S. Taillibert, N. Reyns, F. Barlesi, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review

T. Vuong, R. de Crevoisier, S. Supiot, 2021, Frontiers in Oncology.

[Radiomics: Definition and clinical development].

J. Colinge, C. Bourgier, M. Brengues, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.

G. Calais, J. Bosset, P. Garaud, 2005, International journal of radiation oncology, biology, physics.

MR imaging of locally advanced low rectal cancer: Relationships between imaging findings and the pathological tumor regression grade

S. Nougaret, S. Fujii, C. Reinhold, 2015, Journal of magnetic resonance imaging : JMRI.

[Hypofractionated radiotherapy, a standard in breast cancer?].

C. Bourgier, O. Riou, C. Lemanski, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Debate: Pro intraoperative radiation therapy in breast cancer].

P. Rouanet, C. Lemanski, D. Azria, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Intraoperative radiotherapy for breast cancer

C. Lemanski, D. Azria, 2014, The Lancet.

[Impact of radiotherapy modalities on local control and survival in adjuvant breast cancer treatment].

C. Hennequin, D. Azria, 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network.

M. Amichetti, U. Abacıoğlu, RobertI Miller, 2006, The Lancet. Oncology.

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

T. Conroy, Y. Bécouarn, O. Bouché, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Epidermal growth factor receptor and rectal cancer: in regard to Kim et al. (Int J Radiat Oncol Biol Phys 2006;66:195-200).

F. Bibeau, D. Azria, F. Boissière, 2007, International journal of radiation oncology, biology, physics.

Impact of single‐nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD‐12/PRODIGE‐2 phase III trial

P. Laurent-Puig, V. Boige, J. Gérard, 2019, International journal of cancer.

[Rectal cancer: The radiation basis of radiotherapy, target volume].

J. Bosset, C. Hennequin, J. Gérard, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

Christophe Hennequin, Bernard Denis, Pierre-Luc Etienne, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy.

M. Ychou, J. Duffour, S. Nougaret, 2012, Radiology.

ACCORD12/0405-Prodige 2 Phase III Trial Neoadjuvant Treatment in Rectal Cancer: Results after 3 Years of Follow-up

T. Conroy, P. Romestaing, S. Gourgou-Bourgade, 2011 .

Adjuvant Radioimmunotherapy Trial with Iodine-131–Labeled Anti–Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab′)2 after Resection of Liver Metastases from Colorectal Cancer

M. Ychou, P. Rouanet, C. Bascoul-Mollevi, 2008, Clinical Cancer Research.

Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience

S. Nougaret, H. Addley, S. Fujii, 2013, Journal of magnetic resonance imaging : JMRI.

Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer.

M. Ychou, P. Rouanet, E. Assenat, 2007, International journal of radiation oncology, biology, physics.

p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis

M. Ychou, F. Bibeau, J. Grenier, 2005, British Journal of Cancer.

Cancer des sinus de la face

P. Fenoglietto, M. Hay, D. Azria, 2010 .

[New external radiotherapy technologies for breast cancer].

C. Bourgier, P. Fenoglietto, D. Azria, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Cancer de la prostate

P. Fenoglietto, M. Hay, D. Azria, 2010 .

[Is pelvic irradiation still justified in the treatment of prostate cancer by exclusive radiotherapy?].

L. Quéro, C. Hennequin, O. Chapet, 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Imaged-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating. Concerns about technique and preliminary clinical results.

M. Ychou, P. Rouanet, O. Riou, 2017, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

MD, PhD intravoxel incoherent Motion– derived histogram Metrics for assessment of response after combined chemotherapy and radiation Therapy in rectal cancer: Initial Experience and Comparison between Single-Section and Volumetric

H. Vargas, S. Nougaret, P. Rouanet, 2016 .

Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial.

J. Pignon, T. Conroy, E. Deutsch, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans

C. Lemanski, S. Gourgou, P. Fenoglietto, 2007, Radiation oncology.

In vivo Therapeutic Synergism of Anti–Epidermal Growth Factor Receptor and Anti-HER2 Monoclonal Antibodies against Pancreatic Carcinomas

B. Robert, I. Navarro-Teulon, F. Bibeau, 2007, Clinical Cancer Research.

An asterisk indicates reviewers who have evaluated three or more manuscripts in 2012.

David Ball, Ash A. Alizadeh, David A. August, 2013 .

Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis.

E. Deutsch, C. Bourgier, S. Gourgou, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trial.

S. Culine, X. Rébillard, D. Pouessel, 2012, International journal of radiation oncology, biology, physics.

Bevacizumab in metastatic colorectal cancer: a left intracardiac thrombotic event.

M. Galinier, P. Massabuau, J. Roncalli, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective study.

P. Colombo, P. Rouanet, C. Bourgier, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy.

C. Bourgier, O. Riou, A. Fourquet, 2016, World journal of radiology.

Partial breast irradiation: new standard for selected patients

C. Bourgier, D. Azria, 2010, The Lancet.

[How to combine hormonotherapy and radiation treatment in adjuvant breast cancer?].

K. Zaman, M. Ozsahin, J. Gligorov, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views.

G. Calais, M. Bollet, J. Bosset, 2007, International journal of radiation oncology, biology, physics.

Radiation recall: a well recognized but neglected phenomenon.

N. Magné, S. Culine, R. Stupp, 2005, Cancer treatment reviews.

Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison.

O. Riou, P. Fenoglietto, D. Azria, 2019, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France

S. Oudard, G. Gravis, N. Houédé, 2015, BMC Cancer.

Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice.

B. Robert, P. Martineau, F. Bibeau, 2007, International journal of radiation oncology, biology, physics.

EORTC QLQ-C30 Descriptive Analysis with the qlqc30 Command

C. Bascoul-Mollevi, S. Gourgou-Bourgade, D. Azria, 2015 .

A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort

J. Chang-Claude, A. Dunning, R. Stock, 2020, Frontiers in Oncology.

Resistance to human epidermal growth factor receptor type 2-targeted therapies.

E. Raymond, J. Spano, D. Azria, 2014, European journal of cancer.

[Interest of blood markers in predicting radiation-induced toxicity].

J. Solassol, M. Ozsahin, D. Azria, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Bispecific Antibodies for the Retargeting of Cytokines

B. Robert, A. Pèlegrin, J. Mach, 2011 .

Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett’s oesophagus: report of a case with a favourable behaviour

M. Ychou, E. Assenat, F. Bibeau, 2007, Virchows Archiv.

Phase III randomized French multicentric study to evaluate the impact of a localized 16-Gy boost after conservative surgery and a 50-Gy whole-breast irradiation in breast ductal carcinoma in situ (the BONBIS trial).

P. Maingon, D. Cowen, C. Bourgier, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study.

G. Sasso, J. Gligorov, É. Luporsi, 2011, International journal of radiation oncology, biology, physics.

Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial.

G. Romieu, M. Ozsahin, N. Crompton, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Feasibility study of volumetric modulated arc therapy for the treatment of retroperitoneal sarcomas

P. Fenoglietto, D. Azria, F. Quénet, 2010, Radiation oncology.

Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort

J. Chang-Claude, D. Soria, P. Seibold, 2022, Advances in radiation oncology.

Nutritional support during oncologic treatment of patients with gastrointestinal cancer: who could benefit?

N. Magné, Cyrus Chargari, E. Assenat, 2008, Cancer treatment reviews.

Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management

C. Bourgier, C. Lemanski, S. Gourgou, 2022, Frontiers in Oncology.

Anti-PD-1 for the treatment of advanced cutaneous squamous cell carcinoma in elderly patients: a French multicenter retrospective survey

B. Dréno, O. Dereure, H. Maillard, 2022, Journal of Cancer Research and Clinical Oncology.

Adjuvant chemotherapy alone versus chemoradiation after curative resection for pancreatic cancer : feasibility results of a randomised EORTC/FFCD/GERCOR phase II/III study (40013/22012/0304)

V. Budach, K. Haustermans, G. Tienhoven, 2008 .

Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review.

N. Girard, C. Hennequin, F. Mornex, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma with Combined Radiochemotherapy with 5-Fluorouracil and Cisplatin

M. Ychou, W. Jacot, C. Lemanski, 2002, Pancreas.

Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).

R. Abdah-bortnyak, A. Kuten, U. Abacıoğlu, 2008, Gynecologic oncology.

Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer

M. Ychou, B. Robert, P. Martineau, 2003, British Journal of Cancer.

Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial.

J. Pignon, T. Conroy, E. Deutsch, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Definitive chemoradiation for resectable carcinoma of the cervical esophagus: do we need more evidence?

G. Piessen, A. Adenis, D. Azria, 2017, Annals of translational medicine.

Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure.

T. Mazard, O. Riou, C. Lemanski, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Stage I seminoma and radiotherapy: to bury it or not?].

S. Culine, D. Pouessel, D. Azria, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.

G. Romieu, W. Jacot, J. Ferrero, 2013, Breast.

Aromatase inhibitors decrease radiation-induced lung fibrosis: Results of an experimental study.

N. Sut, N. Beşe, Ş. Yildirim, 2016, Breast.

Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, EBioMedicine.

Prophylactic percutaneous endoscopic gastrostomy in patients with advanced head and neck tumors treated by combined chemoradiotherapy.

E. Assenat, R. Garrel, D. Azria, 2011, Journal of pain and symptom management.

Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: a retrospective rare cancer network study.

L. Moretti, U. Abacıoğlu, RobertI Miller, 2010, Critical reviews in oncology/hematology.

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

J. Chang-Claude, K. Haustermans, P. Seibold, 2022, Frontiers in Oncology.

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Gemcitabine and ionizing radiations: radiosensitization or radio-chemotherapy combination].

S. Culine, M. Ychou, W. Jacot, 2002, Bulletin du cancer.

[Prostate cancer 2010. Therapeutic innovations].

S. Culine, L. Salomon, C. Hennequin, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Radiosensitivity settings in breast cancer].

C. Bourgier, O. Riou, C. Lemanski, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Radioanatomy of rhinopharyngeal carcinoma].

R. Garrel, D. Azria, P. Boisselier, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Radiotherapy of breast cancer].

I. Barillot, M. Leblanc, M. Bollet, 2002, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications

D. Cowen, D. Azria, A. Tallet, 2010, Breast Cancer Research and Treatment.

In Regard to Hepel and Wazer.

P. Lara, D. Azria, F. Izar, 2015, International journal of radiation oncology, biology, physics.

Single Nucleotide Polymorphisms, Apoptosis and the Development of Severe Late Adverse Effects Following Radiotherapy

M. Ozsahin, N. Crompton, B. Rosenstein, 2008 .

Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ.

D. Cowen, C. Bourgier, U. Schick, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Influence of age on chemoradiotherapy outcome in patients with rectal cancer: Exploratory analysis from the phase III study ACCORD 12/0405 PRODIGE 2.

T. Conroy, S. Gourgou-Bourgade, C. Hennequin, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Day-care for breast cancer: ambulatory surgery and intra-operative radiation. Techniques and preliminary results of the Centre Val-d'Aurelle--Montpellier.

P. Colombo, P. Rouanet, C. Lemanski, 2014, Journal of visceral surgery.

Radiation therapy and tamoxifen: concurrent or sequential? It's no longer the question!

R. Mirimanoff, M. Ozsahin, A. Pèlegrin, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined cetuximab, capecitabine, oxaliplatin, and radiotherapy in rectal cancer: Dr. Jekyll or Mr. Hyde? In regard to Rödel et al. (Int J Radiat Oncol Biol Phys 2008;70:1081-1086.).

D. Azria, 2008, International journal of radiation oncology, biology, physics.

Prospective medical analysis of radiation therapist image repositioning during image-guided radiotherapy.

O. Riou, S. Gourgou, P. Fenoglietto, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

In Reply to Dr. Vaidya et al.

C. Lemanski, D. Azria, J. Dubois, 2010 .

Prostate hypofractionated radiation therapy with injection of hyaluronic acid: acute toxicities in a phase 2 study.

E. Decullier, O. Chapet, A. Ruffion, 2015, International journal of radiation oncology, biology, physics.

Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer.

X. Rébillard, R. Boissier, O. Chapet, 2017, Urology.

Radiation Oncology Dosimetric Comparison between Coplanar and Non Coplanar Field Radiotherapy for Ethmoid Sinus Cancer

C. Lemanski, R. Garrel, P. Fenoglietto, 2022 .

ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology.

B. Raaymakers, F. Lagerwaard, C. Belka, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results

O. Riou, P. Fenoglietto, D. Azria, 2022, Journal of clinical medicine.

Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study

M. Ychou, P. Colombo, E. Assenat, 2022, Cancers.

Association of polymorphisms in TGFB1, XRCC1, XRCC3 genes and CD8 T-lymphocyte apoptosis with adverse effect of radiotherapy for prostate cancer

I. Matić, T. Stanojković, M. Brengues, 2022, Scientific reports.

Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).

S. Guérif, R. de Crevoisier, C. Hennequin, 2015, Cancer treatment reviews.

Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study).

D. Cowen, N. Salem, J. Gérard, 2012, International journal of radiation oncology, biology, physics.

High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study).

D. Cowen, N. Salem, J. Gérard, 2011, International journal of radiation oncology, biology, physics.

Spermatic Cord Liposarcoma Associated with Prostate Cancer

L. Guillou, M. Ozsahin, N. Theumann, 2011 .

TNFSF10/TRAIL regulates human T4 effector memory lymphocyte radiosensitivity and predicts radiation-induced acute and subacute dermatitis

H. Perdry, P. Romeo, J. Baijer, 2016, Oncotarget.

Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine.

P. Coucke, L. Decosterd, P. Martineau, 2004, European journal of cancer.

Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.

R. Mirimanoff, F. Luthi, M. Ozsahin, 2006, Archives of otolaryngology--head & neck surgery.

Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers

C. Bascoul-Mollevi, E. Crapez, H. Bazin, 2011, The Journal of Biological Chemistry.

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.

N. Magné, D. Pasquier, S. Chabaud, 2020, The Lancet. Oncology.

A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer

M. Ychou, P. Rouanet, C. Bascoul-Mollevi, 2011, The Pharmacogenomics Journal.

[CCAFU Recommendations 2013: Prostate cancer].

L. Salomon, A. Villers, M. Peyromaure, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study.

D. Pérol, S. Chabaud, V. Beckendorf, 2016, International journal of radiation oncology, biology, physics.

[Partial breast irradiation].

C. Bourgier, O. Riou, C. Lemanski, 2014, Bulletin du cancer.

Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial.

C. Lemanski, P. Fenoglietto, D. Azria, 2010, International journal of radiation oncology, biology, physics.

CD4 and CD8 T-Lymphocyte Apoptosis Can Predict Radiation-Induced Late Toxicity: A Prospective Study in 399 Patients

R. Mirimanoff, M. Ozsahin, N. Crompton, 2005, Clinical Cancer Research.

Treatment of penile carcinoma: to cut or not to cut?

R. Mirimanoff, L. Guillou, R. Moeckli, 2006, International journal of radiation oncology, biology, physics.

Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.

R. Abrams, K. Goodman, D. Azria, 2012, International journal of radiation oncology, biology, physics.

Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies

O. Riou, P. Fenoglietto, D. Azria, 2011, Radiation oncology.

Patients' satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapy.

J. Spano, A. Gonçalves, D. Azria, 2015, Critical reviews in oncology/hematology.

A pilot study of silicone tissue expander prosthesis to protect the small bowel during radiation therapy for uterine malignancies

P. Coucke, J. Delaloye, D. Azria, 2004 .

Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era

P. Lambin, H. Thierens, J. Chang-Claude, 2017, Front. Oncol..

Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.

M. Ychou, P. Rouanet, F. Viret, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[French ccAFU guidelines - Update 2018-2020: Prostate cancer].

A. Ouzzane, G. Cancel-Tassin, O. Cussenot, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Fetal dose reduction in head and neck radiotherapy of a pregnant woman.

R. Mirimanoff, R. Moeckli, M. Ozsahin, 2004, Zeitschrift fur medizinische Physik.

Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.

M. Ozsahin, J. Kaanders, D. Azria, 2010, International journal of radiation oncology, biology, physics.

[French ccAFU guidelines - Update 2018-2020: Prostate cancer].

A. Ouzzane, G. Cancel-Tassin, O. Cussenot, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.

M. Colombel, O. Chapet, A. Ruffion, 2014, International journal of radiation oncology, biology, physics.

Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall.

M. Colombel, O. Chapet, A. Ruffion, 2013, International journal of radiation oncology, biology, physics.

Optimal timing for adjuvant radiation therapy in breast cancer: a comprehensive review and perspectives.

M. Koukourakis, Y. Belkacemi, D. Azria, 2009, Critical reviews in oncology/hematology.

Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence.

M. Héry, M. Namer, H. Marsiglia, 2011, Critical reviews in oncology/hematology.

Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.

G. Calais, J. Bosset, P. Garaud, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In reply to Drs. Munshi and Jalali

G. Calais, A. Fourquet, D. Azria, 2006 .

[CCAFU french national guidelines 2016-2018 on prostate cancer].

A. Ouzzane, G. Cancel-Tassin, O. Cussenot, 2016, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

New concept for immediate breast reconstruction for invasive cancers: feasibility, oncological safety and esthetic outcome of post-neoadjuvant therapy immediate breast reconstruction versus delayed breast reconstruction: a prospective pilot study

J. Daurès, D. Azria, G. Rathat, 2010, Breast Cancer Research and Treatment.

The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications

M. Ozsahin, D. Azria, A. Zouhair, 2006, Radiation oncology.

Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations

S. Richard, O. Cussenot, A. Cambon-Thomsen, 2018, European Journal of Human Genetics.

Cell Membrane is a More Sensitive Target than Cytoplasm to Dense Ionization Produced by Auger Electrons

Manuel Bardiès, André Pèlegrin, Nicolas Chouin, 2008, Radiation research.

External radiotherapy and anaemia treatment: state of the art.

R. Mirimanoff, M. Ozsahin, D. Azria, 2005, Swiss medical weekly.

Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the “THERAPY”phase 1-2 trial

M. Ychou, B. Robert, E. Crapez, 2015, Oncotarget.

Nanoparticles as contrast agents for brain nuclear magnetic resonance imaging in Alzheimer's disease diagnosis.

S. Blanquer, D. Azria, J. Verdier, 2017, Journal of materials chemistry. B.

Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma

M. Ychou, E. Assenat, O. Riou, 2021, Cancers.

Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations

S. Richard, O. Cussenot, A. Cambon-Thomsen, 2018, European Journal of Human Genetics.

Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.

J. Bourhis, P. Taourel, N. Lassau, 2019, International journal of radiation oncology, biology, physics.

Tumour and normal tissue radiosensitivity.

L. Quéro, F. Milliat, M. Brengues, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.

L. Collette, V. Budach, K. Haustermans, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray

M. Ychou, F. Penault-Llorca, P. Rochaix, 2006, Virchows Archiv.

Multidisciplinary approach of early breast cancer: The biology applied to radiation oncology

M. Ozsahin, C. Bourgier, D. Azria, 2010, Radiation oncology.

[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique].

I. Barillot, J. Ferlay, C. de Martel, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Simultaneous integrated boost plan comparison of volumetric‐modulated arc therapy and sliding window intensity‐modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer

Olivier Riou, David Azria, O. Riou, 2013, Journal of applied clinical medical physics.

Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction

D. Cowen, D. Azria, M. Resbeut, 2015, Gastroenterology research and practice.

Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancer.

V. Fonteyne, J. Christodouleas, M. Rouprêt, 2019, Critical reviews in oncology/hematology.

[RapidArc technology: first year of experience at the Montpellier comprehensive cancer centre].

C. Lemanski, P. Fenoglietto, D. Azria, 2010, Bulletin du cancer.

Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: focus on clinical trials and perspectives.

M. Namer, D. Khayat, J. Spano, 2007, Critical reviews in oncology/hematology.

Management of the Axilla in the Era of Breast Cancer Heterogeneity

C. Bourgier, C. Lemanski, P. Fenoglietto, 2018, Front. Oncol..

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S Michiels, B Asselain, J Bogaerts, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment

F. Barlesi, J. Spano, P. Metellus, 2012, Radiation oncology.

Genetic predictors of adverse radiotherapy effects: the Gene-PARE project.

R. Stock, A. Kuten, J. Overgaard, 2006, International journal of radiation oncology, biology, physics.

Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment

Jean-Philippe Spano, David Azria, Philippe Metellus, 2012, Radiation Oncology.

[How to treat brain metastasis in 2012?].

W. Jacot, F. Mornex, P. Metellus, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study

P. Giraud, N. Salem, D. Peiffert, 2022, Frontiers in Oncology.

[Paranasal sinus carcinoma].

P. Fenoglietto, M. Hay, D. Azria, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Decrease in Hemoglobin Levels Following Surgery Influences the Outcome in Head and Neck Cancer Patients Treated with Accelerated Postoperative Radiotherapy

R. Mirimanoff, F. Luthi, M. Ozsahin, 2009, Annals of Surgical Oncology.

Phyllodes tumor of the breast.

N. Magné, I. Ray-Coquard, M. Ozsahin, 2008, International journal of radiation oncology, biology, physics.

Randomized multicenter phase III trial comparing two neoadjuvant chemoradiotherapy (CT-RT) regimens (RT45-Cap versus RT50-Capox) in patients (pts) with locally advanced rectal cancer (LARC): Results of the ACCORD 12/0405 PRODIGE 2.

T. Conroy, S. Gourgou-Bourgade, C. Hennequin, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials.

D. Hamstra, M. D. De Santis, A. Choudhury, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Decreased Local Control Following Radiation Therapy Alone in Early-Stage Glottic Carcinoma with Anterior Commissure Extension*

R. Mirimanoff, P. Coucke, R. Moeckli, 2004, Strahlentherapie und Onkologie.

Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases

G. Romieu, W. Jacot, J. Ferrero, 2013, BMC Cancer.

Comparison of volumetric‐modulated arc therapy and dynamic conformal arc treatment planning for cranial stereotactic radiosurgery

P. Fenoglietto, C. Kerr, D. Azria, 2016, Journal of applied clinical medical physics.

Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center

X. Rébillard, O. Riou, P. Fenoglietto, 2012, ISRN urology.

[Adenoid cystic carcinoma of the head and neck: a retrospective series of 169 cases].

D. Cowen, K. Bénézery, D. Azria, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials].

S. Culine, M. Ychou, B. Robert, 2003, Bulletin du cancer.

Clinical radioimmunotherapy—the role of radiobiology

I. Navarro-Teulon, A. Pèlegrin, M. Bardiès, 2011, Nature Reviews Clinical Oncology.

Rationale for the Use of Upfront Whole Brain Irradiation in Patients with Brain Metastases from Breast Cancer

S. Taillibert, F. Barlesi, J. Spano, 2014, International journal of molecular sciences.

Magnetic Resonance–Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry Study

O. Riou, P. Fenoglietto, D. Azria, 2021, Advances in radiation oncology.

[What type of hypofractionated radiotherapy of primary tumours in palliative care?].

C. Bourgier, D. Azria, P. Boisselier, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models

P. Colombo, F. Penault-Llorca, N. Radosevic-Robin, 2014, Oncotarget.

In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption.

C. Bascoul-Mollevi, B. Robert, A. Pèlegrin, 2012, Neoplasia.

Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts.

F. Penault-Llorca, C. Bascoul-Mollevi, B. Robert, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

MONOCLONALAND BISPECIFIC ANTIBODIES IN COMBINATIONWITH RADIOTHERAPYFOR CANCERTREATMENT

B. Robert, D. Azria, C. Larbouret, 2004 .

Monoclonal and Bispecific Antibodies in Combination with Radiotherapy for Cancer Treatment

B. Robert, M. Ozsahin, A. Pèlegrin, 2004 .

Growth of breast cancer recurrences assessed by consecutive MRI

P. Taourel, I. Millet, D. Hoa, 2011, BMC Cancer.

Evaluation of reproducibility of tumor repositioning during multiple breathing cycles for liver stereotactic body radiotherapy treatment.

O. Riou, P. Fenoglietto, D. Azria, 2017, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group.

M. Bolla, S. Guérif, C. Hennequin, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of Angiotensin Converting Enzyme Inhibitors is Associated with Reduced Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer.

Tim E. Ward, J. Chang-Claude, E. Messing, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapy

Daniele Soria, Thierry J. Chaussalet, Barry S. Rosenstein, 2021, Comput. Biol. Medicine.

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

J. Chang-Claude, A. Dunning, R. Stock, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort

J. Chang-Claude, A. Dunning, P. Seibold, 2020, Frontiers in Oncology.

XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.

J. Chang-Claude, J. Debus, A. Dunning, 2015, International journal of radiation oncology, biology, physics.

The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors.

P. Lambin, P. Lambin, H. Thierens, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics

Joseph O Deasy, Alison M Dunning, Jenny Chang-Claude, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Establishment of a Radiogenomics Consortium.

Andrzej Polanski, Karin Haustermans, Barry Rosenstein, 2010, International journal of radiation oncology, biology, physics.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5,456 breast and prostate cancer patients

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

ATM rs1801516 SNP and toxicity after radiotherapy

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

Requite: Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality-of-Life in Cancer Survivors

J. Chang-Claude, P. Seibold, D. Ruysscher, 2019, International Journal of Radiation Oncology*Biology*Physics.

Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement.

P. Lambin, D. de Ruysscher, T. Ward, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A prospective phase II study evaluating the efficacy of oral immune modulating formulae on acute oral mucositis during radiochemotherapy in head and neck neoplasms

E. Crapez, E. Assenat, S. Gaillet, 2011 .

Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells.

C. Bourgier, M. Jarlier, A. Pèlegrin, 2020, International journal of radiation oncology, biology, physics.

Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer

C. Lemanski, S. Gourgou, P. Fenoglietto, 2010, Radiation oncology.

[Doses to organs at risk for conformational and stereotactic radiotherapy: Bladder].

R. Crevoisier, J. Castelli, R. de Crevoisier, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Cancers du rectum : volumes cible de la radiothérapie, bases rationnelles

J. Bosset, C. Hennequin, J. Gérard, 2011 .

EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancer

M. Ychou, P. Rouanet, C. Bascoul-Mollevi, 2011, International journal of cancer.

Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.

R. Mirimanoff, R. Stupp, M. Ozsahin, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study.

M. Namer, M. Ozsahin, H. Marsiglia, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]].

M. Espié, D. Cox, R. Rouzier, 2016, Bulletin du cancer.

Enhancement of radiation therapy by tumor necrosis factor alpha in human colon cancer using a bispecific antibody.

André Pèlegrin, Sophie Gourgou, Pierre Martineau, 2003, International journal of radiation oncology, biology, physics.

Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study

M. Ychou, E. Assenat, T. Mazard, 2023, Journal of clinical medicine.

[Which intensity modulated radiation therapy? From "step and shoot" to volumetric modulated arc therapy, point of view of the radiation oncologist].

C. Lemanski, P. Fenoglietto, D. Azria, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study

J. Thariat, O. Riou, P. Fenoglietto, 2014, Radiation oncology.

[Management of brain metastases for lung cancer patients].

Jean Régis, Jean-Philippe Spano, David Azria, 2013, Bulletin du cancer.

Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy.

P. Crochet, P. Rouanet, P. Taourel, 2018, Critical reviews in oncology/hematology.

Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry Study

O. Riou, S. Gourgou, P. Fenoglietto, 2022, Cancers.

[Combination of anti-EGFR and anti-HER2 antibodies: hope in pancreatic cancer treatment].

B. Robert, E. Assenat, A. Pèlegrin, 2007, Bulletin du cancer.

Adjuvant radiotherapy in the management of axillary node negative invasive breast cancer: a qualitative systematic review.

M. Bollet, C. Bourgier, C. Hennequin, 2013, Critical reviews in oncology/hematology.

Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease

L. Collette, P. Maingon, M. Bolla, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients

R. Mirimanoff, G. Romieu, M. Ozsahin, 2004, British Journal of Cancer.

Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy

C. Bourgier, C. Lemanski, S. Gourgou, 2023, Frontiers in Oncology.

Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses.

H. Vargas, S. Nougaret, P. Rouanet, 2016, Radiology.

An ambispective observational study in the safety and efficacy of abiraterone acetate in the French temporary authorizations for use (ATU): Predictive parameters of response.

S. Culine, S. Oudard, G. Gravis, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[The use of breast cancer subtype classification to predict local and distant recurrence. A review].

F. Penault-Llorca, J. Gligorov, Y. Belkacemi, 2008, Cancer Radiothérapie.

Does short-term androgen depletion add to high-dose radiotherapy (80 Gy) in localized intermediate-risk prostate cancer? Intermediary analysis of GETUG 14 randomized trial (EU-20503/NCT00104741).

B. Dubray, J. Bachaud, S. Guérif, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder.

N. Magné, S. Culine, R. de Crevoisier, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study.

J. Bosset, P. Maingon, C. Borg, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.

K. Zaman, G. Romieu, M. Ozsahin, 2010, The Lancet. Oncology.

Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial

Norbert Ailleres, Philippe Rouanet, David Azria, 2013, Radiation oncology.

Adjuvant breast radiotherapy in patients aged 65 and over: Not a binary decision

C. Bourgier, C. Lemanski, D. Azria, 2023, Cancer/Radiothérapie.

Focal HIFU for prostate cancer.

P. Maingon, D. Peiffert, D. Azria, 2012, The Lancet. Oncology.

[Biologic modulation of ionizing radiation by Toll-like receptors agonists: towards an increase in the therapeutic index of radiotherapy?].

B. Robert, O. Riou, D. Azria, 2012, Bulletin du cancer.

TIME RESOLVED FLUORESCENCE RESONANCE ENERGY TRANSFER (TR-FRET) TO ANALYZE THE DISRUPTION OF EGFR/HER2 DIMERS: A NEW METHOD TO EVALUATE THE EFFICIENCY OF TARGETED THERAPY USING MONOCLONAL ANTIBODIES

E. Crapez, H. Bazin, G. Mathis, 2011 .

[Angiogenesis inhibitors and radiation therapy: from biology to clinical practice].

D. Azria, R. Mazeron, E. Deutsch, 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

ACCORD12/0405-Prodige 2 phase III trial neoadjuvant treatment in rectal cancer: Results after 5 years of follow-up.

T. Conroy, O. Bouché, S. Gourgou-Bourgade, 2016 .

Advanced penile cancer with iliac lymph node involvement treated with radiation and concurrent gemcitabine.

N. Mottet, O. Riou, D. Azria, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).

H. Wildiers, J. Bogaerts, J. Yarnold, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer

M. Ychou, P. Rouanet, M. Ozsahin, 2005, BMC Cancer.

News in magnetic resonance imaging use for radiation oncology.

O. Riou, D. Azria, C. Decoene, 2022, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Correlation between radio-induced lymphocyte apoptosis measurements obtained from two French centres.

P. Maingon, J. Merlin, D. Azria, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Online verification of intrafraction motion in VMAT stereotactic prostate treatment

O. Riou, P. Fenoglietto, D. Azria, 2013 .

Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.

P. Rouanet, C. Lemanski, P. Fenoglietto, 2006, International journal of radiation oncology, biology, physics.

[Practical update of total dose compensation in case of temporary interruption of external radiotherapy in the COVID-19 pandemic context].

P. Giraud, C. Hennequin, D. Azria, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

External irradiation treatment process.

I. Barillot, D. Azria, A. Lisbona, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Robustness of Breast Margins with Volumetric Modulated Arc Therapy without a Six-Degrees-of-Freedom Couch: A Dosimetric Evaluation

C. Bourgier, P. Fenoglietto, D. Azria, 2023, Journal of clinical medicine.

Role of the Radiotherapy Boost on Local Control in Ductal Carcinoma In Situ

O. Riou, C. Lemanski, P. Fenoglietto, 2012, International journal of surgical oncology.

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiation after curative resection for pancreatic cancer: Updated results of a randomized EORTC/FFCD/GERCOR phase II study (40013-22012/9203).

V. Budach, K. Haustermans, E. Van Cutsem, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.

Norbert Ailleres, Sophie Gourgou, David Azria, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Evaluation of immediate breast reconstruction and radiotherapy: factors associated with complications].

P. Rouanet, D. Cowen, G. Houvenaeghel, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Breathing adapted radiotherapy: a 4D gating software for lung cancer

Habib Zaidi, Osman Ratib, Michael Wissmeyer, 2011, Radiation oncology.

Cetuximab plus radiochemotherapy in locally advanced anal cancer: Interim results of the French multicenter phase II trial ACCORD16.

J. Pignon, Y. Bécouarn, J. Bérille, 2011, Journal of Clinical Oncology.

IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center

C. Lemanski, S. Gourgou, P. Fenoglietto, 2012, Radiation oncology.

Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey.

Michael Baumann, Valentin Cernea, Vydmantas Atkocius, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Anti-PD-1 for the treatment of advanced cutaneous squamous cell carcinoma in elderly patients: a French multicenter retrospective survey

B. Dréno, O. Dereure, H. Maillard, 2022, Journal of Cancer Research and Clinical Oncology.

Implementing intensity modulated radiotherapy to the prostate bed: dosimetric study and early clinical results.

O. Riou, P. Fenoglietto, D. Azria, 2013, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator

C. Bourgier, M. Brengues, S. Gourgou, 2018, Front. Oncol..

Adenoid Cystic Carcinoma Of The Head and Neck: Retrospective Series Of 169 Cases

D. Cowen, N. Salem, D. Azria, 2011 .

[Ductal carcinoma in situ: role of the boost].

I. Barillot, P. Maingon, A. Monnier, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

A bispecific antibody to enhance radiotherapy by tumor necrosis factor-alpha in human CEA-expressing digestive tumors.

B. Robert, P. Martineau, S. Gourgou, 2004, International journal of radiation oncology, biology, physics.

Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients

C. Bourgier, O. Riou, C. Lemanski, 2015, Radiation oncology.

[Intensity modulated radiotherapy for breast cancer].

O. Riou, C. Lemanski, P. Fenoglietto, 2012, Cancer Radiothérapie.

High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemes.

E. Chamorey, J. Hannoun-levi, D. Azria, 2017, Brachytherapy.

Implementation of the Calypso system: a commissioning experience

O. Riou, P. Fenoglietto, D. Azria, 2023, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].

G. Romieu, M. Ozsahin, C. Lemanski, 2004, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Eight years of IMRT quality assurance with ionization chambers and film dosimetry: experience of the montpellier comprehensive cancer center

Olivier Riou, David Azria, O. Riou, 2011, Radiation oncology.

The role of radiation therapy for de novo metastatic bladder and renal cancers.

R. de Crevoisier, D. Pasquier, P. Blanchard, 2023, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

J. Solassol, A. Mangé, M. Ozsahin, 2019, Radiation oncology.

Acceptance, commissioning and quality assurance of the MRIdian®: Site experience and three years follow-up.

O. Riou, P. Fenoglietto, D. Azria, 2023, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Postoperative radiotherapy for prostate cancer].

P. Fenoglietto, M. Hay, D. Azria, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

A Wake-Up Call for Routine Morbidity and Mortality Review Meeting Procedures as Part of a Quality Governance Programs in Radiation Therapy Departments: Results of the PROUST Survey.

David Azria, M. Bollet, Y. Belkacemi, 2019, Practical radiation oncology.

Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.

J. Chang-Claude, C. Luccarini, P. Seibold, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).

Tim E. Ward, J. Chang-Claude, A. Dunning, 2022, Lung Cancer.

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans

C. Lemanski, S. Gourgou, P. Fenoglietto, 2007, Radiation oncology.

EM algorithm estimation of a structural equation model for the longitudinal study of the quality of life

C. Lavergne, C. Bascoul-Mollevi, S. Gourgou, 2018, Statistics in medicine.

Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey.

H. Cohen, K. Hoang-Xuan, S. Culine, 2018, European journal of cancer.

The value of endoscopic rectal ultrasound in predicting the lateral clearance and outcome in patients with lower-third rectal adenocarcinoma.

P. Rouanet, E. Assenat, F. Bibeau, 2007, Endoscopy.

[Partial breast irradiation].

C. Bourgier, O. Riou, C. Lemanski, 2014, Bulletin du cancer.

[RHESOU (Registry in HErault Specialized in Onco-Urology) : the first French Registry specialized in Onco-Urology. One-year experience].

J. Daurès, X. Rébillard, B. Trétarre, 2020, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Ann Oncol . Author Manuscript Combined Cetuximab and Trastuzumab Are Superior to Gemcitabine in the Treatment of Human Pancreatic Carcinoma Xenografts

C. Bascoul-Mollevi, B. Robert, I. Navarro-Teulon, 2022 .

Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts

C. Bascoul-Mollevi, I. Navarro-Teulon, A. Pèlegrin, 2009 .

(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Tim E. Ward, J. Chang-Claude, P. Seibold, 2023, International journal of cancer.

Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study

M. Ychou, P. Colombo, E. Assenat, 2022, Frontiers in Oncology.

[Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?]

T. Mazard, O. Riou, P. Fenoglietto, 2019, Cancer Radiothérapie.

Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial.

J. Pignon, T. Conroy, Y. Bécouarn, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques.

M. Ychou, E. Assenat, O. Riou, 2017, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[Stereotactic body radiotherapy of primary liver tumours: Indications and new techniques].

O. Riou, D. Azria, D. Azria, 2022, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays

K. Pantel, M. Nowicki, M. Zabel, 2019, Cancers.

Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study.

G. Mantion, D. Azria, J. Bosset, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

T. Conroy, S. Gourgou-Bourgade, C. Hennequin, 2009, Journal of Clinical Oncology.

Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD

C. Bascoul-Mollevi, Marion Savina, Amélie Anota, 2018, Comput. Methods Programs Biomed..

[Clinical trials in Radiation Oncology: Methodologic approach].

S. Gourgou, D. Azria, D. Azria, 2022, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Elaboration of Materials with Functionality Gradients by Assembly of Chitosan-Collagen Microspheres Produced by Microfluidics

S. Blanquer, M. Morille, D. Azria, 2018 .

High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study).

D. Cowen, N. Salem, J. Gérard, 2011, International journal of radiation oncology, biology, physics.

[CCAFU french national guidelines 2016-2018 on prostate cancer].

A. Ouzzane, G. Cancel-Tassin, O. Cussenot, 2016, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

PRODIGE 2 phase III trial neoadjuvant in rectal cancer: Quality of life and results at 5 years.

T. Conroy, P. Rouanet, O. Bouché, 2016 .

[The breakthrough of personalized medicine, new hopes and new challenges].

A. Schernberg, R. Flippot, L. Verlingue, 2017, Bulletin du cancer.

Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.

M. Ychou, P. Rouanet, F. Viret, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement.

P. Lambin, D. de Ruysscher, T. Ward, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intraoperative Technique with Electrons

C. Lemanski, D. Azria, 2016 .

[Partial breast irradiation].

C. Bourgier, O. Riou, C. Lemanski, 2014, Bulletin du cancer.

[CCAFU Recommendations 2013: Prostate cancer].

A. Villers, M. Peyromaure, P. Beuzeboc, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients

C. Bourgier, O. Riou, C. Lemanski, 2015, Radiation Oncology.